PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 126 filers reported holding PLIANT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,153,869 | -55.9% | 181,884 | -53.9% | 0.00% | -33.3% |
| Q2 2023 | $7,154,918 | +72245.0% | 394,863 | +6.2% | 0.00% | -50.0% |
| Q1 2023 | $9,890 | +147.5% | 371,803 | +79.8% | 0.01% | +200.0% |
| Q4 2022 | $3,996 | -99.9% | 206,731 | +6.6% | 0.00% | 0.0% |
| Q3 2022 | $4,050,000 | +129.6% | 193,882 | -12.0% | 0.00% | +100.0% |
| Q2 2022 | $1,764,000 | +333.4% | 220,213 | +279.2% | 0.00% | – |
| Q1 2022 | $407,000 | -53.1% | 58,067 | -9.6% | 0.00% | – |
| Q4 2021 | $868,000 | +53.9% | 64,263 | +92.4% | 0.00% | – |
| Q3 2021 | $564,000 | +11.9% | 33,396 | +92.8% | 0.00% | – |
| Q2 2021 | $504,000 | -79.8% | 17,319 | -72.7% | 0.00% | -100.0% |
| Q1 2021 | $2,492,000 | +245.2% | 63,366 | +99.3% | 0.00% | +100.0% |
| Q4 2020 | $722,000 | +86.1% | 31,796 | +85.4% | 0.00% | – |
| Q3 2020 | $388,000 | -82.9% | 17,148 | -75.5% | 0.00% | -100.0% |
| Q2 2020 | $2,274,000 | – | 70,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |